P Rys

581 total citations
22 papers, 324 citations indexed

About

P Rys is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Economics and Econometrics. According to data from OpenAlex, P Rys has authored 22 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Genetics and 5 papers in Economics and Econometrics. Recurrent topics in P Rys's work include Diabetes Management and Research (11 papers), Diabetes Treatment and Management (8 papers) and Diabetes and associated disorders (6 papers). P Rys is often cited by papers focused on Diabetes Management and Research (11 papers), Diabetes Treatment and Management (8 papers) and Diabetes and associated disorders (6 papers). P Rys collaborates with scholars based in Poland, Austria and United Kingdom. P Rys's co-authors include Maciej T. Małecki, Piotr Wojciechowski, Joanna Lis, Agnieszka H. Ludwig‐Słomczyńska, Katarzyna Cyganek, Anna M. Lipowska, Aleksandra Wieczorek, Magdalena Władysiuk, Marek L. Kowalski and Robert Ślepaczuk and has published in prestigious journals such as PLoS ONE, European Journal of Endocrinology and Digestive Diseases and Sciences.

In The Last Decade

P Rys

22 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Rys Poland 10 222 95 69 30 28 22 324
Shiva Borzouei Iran 13 116 0.5× 57 0.6× 41 0.6× 52 1.7× 34 1.2× 55 357
Hubert S. Chou United States 9 325 1.5× 117 1.2× 95 1.4× 100 3.3× 10 0.4× 12 453
Samiul Mostafa United Kingdom 14 317 1.4× 36 0.4× 39 0.6× 83 2.8× 17 0.6× 28 442
Gemma Carreras Spain 11 189 0.9× 117 1.2× 86 1.2× 31 1.0× 17 0.6× 12 345
Jennal Johnson United States 11 316 1.4× 74 0.8× 71 1.0× 74 2.5× 16 0.6× 28 418
Ellie S. Strock United States 11 413 1.9× 150 1.6× 153 2.2× 49 1.6× 12 0.4× 24 490
Uchenna Anyanwagu United Kingdom 11 154 0.7× 82 0.9× 17 0.2× 39 1.3× 8 0.3× 24 302
Nicoletta Musacchio Italy 9 185 0.8× 48 0.5× 29 0.4× 22 0.7× 11 0.4× 22 343
K.M. Shelgikar India 10 125 0.6× 90 0.9× 65 0.9× 41 1.4× 9 0.3× 14 302
Winston Crasto United Kingdom 8 201 0.9× 66 0.7× 50 0.7× 34 1.1× 3 0.1× 18 318

Countries citing papers authored by P Rys

Since Specialization
Citations

This map shows the geographic impact of P Rys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Rys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Rys more than expected).

Fields of papers citing papers by P Rys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Rys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Rys. The network helps show where P Rys may publish in the future.

Co-authorship network of co-authors of P Rys

This figure shows the co-authorship network connecting the top 25 collaborators of P Rys. A scholar is included among the top collaborators of P Rys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Rys. P Rys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rys, P, et al.. (2025). Pancreatic Enzyme Replacement Therapy in Pancreatic Exocrine Insufficiency—Real-World’s Dosing and Effectiveness: A Systematic Review. Digestive Diseases and Sciences. 70(7). 2270–2284. 2 indexed citations
2.
Mader, Julia K., Ahmed Hassoun, Lutz Heinemann, et al.. (2025). Existing Knowledge Gaps in Risk Factors and Consequences of Lipohypertrophy in People Using Continuous Subcutaneous Insulin Infusion Therapy: A Systematic Review and Meta-analysis. Journal of Diabetes Science and Technology. 580929022–580929022. 1 indexed citations
3.
Mader, Julia K., Ahmed Hassoun, Lutz Heinemann, et al.. (2025). Risk factors for Lipohypertrophy in People With Insulin-Treated Diabetes: A Systematic Meta-Analysis. Journal of Diabetes Science and Technology. 580934785–580934785. 2 indexed citations
4.
Mader, Julia K., Ahmed Hassoun, Lutz Heinemann, et al.. (2024). Relationship Between Lipohypertrophy, Glycemic Control, and Insulin Dosing: A Systematic Meta-Analysis. Diabetes Technology & Therapeutics. 26(5). 351–362. 5 indexed citations
5.
Rys, P, et al.. (2023). Energy and cost efficiency of Bitcoin mining endeavor. PLoS ONE. 18(3). e0283687–e0283687. 7 indexed citations
6.
Walicka, Magdalena, et al.. (2020). Epidemiologia cukrzycy w Polsce w latach 2014–2017. 6(5). 284–291. 1 indexed citations
7.
Rys, P, Jerzy Hohendorff, Przemysław Witek, et al.. (2020). NPWT in diabetic foot wounds—a systematic review and meta-analysis of observational studies. Endocrine. 68(1). 44–55. 11 indexed citations
8.
Walicka, Magdalena, et al.. (2020). Epidemiology of diabetes in Poland in 2014–2017. Clinical Diabetology. 9(5). 279–285. 9 indexed citations
9.
Rys, P & Robert Ślepaczuk. (2018). Machine Learning Methods in Algorithmic Trading Strategy Optimization – Design and Time Efficiency. RePEc: Research Papers in Economics. 5(52). 206–229. 4 indexed citations
10.
Kowalski, Marek L., et al.. (2016). Adrenal suppression by inhaled corticosteroids in patients with asthma: A systematic review and quantitative analysis. Allergy and Asthma Proceedings. 37(1). 9–17. 18 indexed citations
11.
Wojciechowski, Piotr, et al.. (2015). Clinical efficacy and safety of insulin aspart compared with regular human insulin in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis. Polskie Archiwum Medycyny Wewnętrznej. 125(3). 141–151. 8 indexed citations
14.
Lis, Joanna, et al.. (2011). PMH34 Cost-Utility of Amisulpride Compared with First Generation Antipsychotics in Treatment of Schizophrenia in Poland. Value in Health. 14(7). A292–A292. 2 indexed citations
17.
Rys, P, et al.. (2010). Cost-utility analysis for insulin aspart and biphasic insulin aspart in treatment of type 1 and 2 diabetes mellitus. Clinical Diabetology. 11(1). 24–34. 3 indexed citations
18.
Rys, P, et al.. (2009). Review articles, systematic reviews and meta‑analyses: which can be trusted?. Polskie Archiwum Medycyny Wewnętrznej. 119(3). 148–156. 17 indexed citations
19.
Władysiuk, Magdalena, et al.. (2009). PCN120 COST-UTILITY OF DOCETAXEL COMPARED WITH BEST SUPPORTIVE CARE AND PEMETREXED IN SECOND LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN POLAND. Value in Health. 12(7). A280–A280. 1 indexed citations
20.
Wieczorek, Aleksandra, et al.. (2008). The Role of Surrogate Endpoints in the Evaluation of Efficacy and Safety of Therapeutic Interventions in Diabetes Mellitus. The Review of Diabetic Studies. 5(3). 128–135. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026